Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/02/1998 | US5759803 Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA |
06/02/1998 | US5759802 Production of human serum alubumin A |
06/02/1998 | US5759801 Δ5,7 -sterol reductase from arabidopsis thaliana |
06/02/1998 | US5759790 Von Hippel - Lindau (VHL) disease gene and corresponding cDNA and methods for detecting carriers of the VHL disease gene |
06/02/1998 | US5759789 Prostaglandin receptor EP2 |
06/02/1998 | US5759788 High affinity L-proline transporter polypeptides; antibodies and immunoassays specific for them |
06/02/1998 | US5759784 Method of nucleic acid transfer |
06/02/1998 | US5759783 Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene |
06/02/1998 | US5759778 Method of nucleic acid sequence selection |
06/02/1998 | US5759776 Targets for breast cancer diagnosis and treatment |
06/02/1998 | US5759775 Hybridization; amplification |
06/02/1998 | US5759773 Sensitive nucleic acid sandwich hybridization assay |
06/02/1998 | US5759771 Method of determining a genotype by comparing the nucleotide sequence of members of a gene family and kit therefor |
06/02/1998 | US5759770 Retrovirus from the HIV group and its use |
06/02/1998 | US5759769 Diagnostic kits, vaccines; immobilized peptide having amino acid sequence epitope |
06/02/1998 | US5759553 Polypeptides |
06/02/1998 | US5759552 Marek's disease virus recombinant poxvirus vaccine |
06/02/1998 | US5759546 Treatment of CD4 T-cell mediated conditions |
06/02/1998 | US5759538 Bacillus thuringiensis apr and npr genes, apr and npr B.t. strains, and method of use |
06/02/1998 | US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses |
06/02/1998 | US5759533 Neutrophil-activating peptide-2 |
06/02/1998 | US5759519 Method for the intracellular delivery of biomolecules using thiocationic lipids |
06/02/1998 | US5759517 Hemoglobins as drug delivery agents |
06/02/1998 | CA1339894C Fusion proteins with a eukaryotic ballast portion |
06/02/1998 | CA1339893C Procaryotic carbonyl hydrolases |
06/02/1998 | CA1339892C Preparation of polypeptides having human gamma enterferon activity |
05/29/1998 | CA2217159A1 Multifunctional ligand system for cell-specific transfer of nucleic acid |
05/28/1998 | WO1998022623A2 Cdna collections encoding proteins regulated during programmed cell death, and methods of use thereof |
05/28/1998 | WO1998022622A1 Method for identifying mutants and molecules |
05/28/1998 | WO1998022610A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes |
05/28/1998 | WO1998022609A1 Chimeric adenoviral vectors |
05/28/1998 | WO1998022608A2 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
05/28/1998 | WO1998022607A1 Method for producing recombinant virus |
05/28/1998 | WO1998022606A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia |
05/28/1998 | WO1998022605A1 Improved methods for transducing cells |
05/28/1998 | WO1998022604A1 Methods of producing high-oil seed by modification of starch levels |
05/28/1998 | WO1998022602A1 Zearalenone detoxification compositions and methods |
05/28/1998 | WO1998022601A1 Heat stable mutants of starch biosynthesis enzymes |
05/28/1998 | WO1998022600A1 Transgenic plant or plants with a naturally high water content overproducing at least two amino acids of the aspartate family |
05/28/1998 | WO1998022599A1 Nematode-inducible regulatory dna sequences |
05/28/1998 | WO1998022598A1 Methods for producing polypeptides in surfactin mutants of bacillus cells |
05/28/1998 | WO1998022597A2 Cloning and characterization of napsin, an aspartic protease |
05/28/1998 | WO1998022596A1 RECOMBINANT VACCINIA VIRUS, PROCESS FOR PREPARING Gag PROTEIN PARTICLE STRUCTURE USING THE SAME, PARTICLE PREPARED BY SAID PROCESS, AND USE THEREOF |
05/28/1998 | WO1998022595A1 Broad-spectrum delta-endotoxins |
05/28/1998 | WO1998022594A1 Compositions and methods for plant pathogen resistance |
05/28/1998 | WO1998022593A1 P gene promoter constructs for floral-tissue preferred gene expression |
05/28/1998 | WO1998022592A1 Agl15 sequences in transgenic plants |
05/28/1998 | WO1998022591A2 Carrot antifreeze polypeptides |
05/28/1998 | WO1998022590A1 Process for preparing antibody molecules |
05/28/1998 | WO1998022589A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
05/28/1998 | WO1998022588A2 An improved method for the production and purification of adenoviral vectors |
05/28/1998 | WO1998022587A2 Pituitary-tumor-transforming-genes, and related products |
05/28/1998 | WO1998022586A2 HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR |
05/28/1998 | WO1998022585A1 HUMAN POLYHOMEOTIC 2(hph2) ACTS AS AN ONCOGENE |
05/28/1998 | WO1998022584A1 C1q RECEPTOR, ENCODING GENE AND APPLICATION IN HOST DEFENSE ENHANCEMENT |
05/28/1998 | WO1998022583A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION |
05/28/1998 | WO1998022582A1 Human cancer regression antigen protein |
05/28/1998 | WO1998022581A1 Transcription repressor |
05/28/1998 | WO1998022580A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
05/28/1998 | WO1998022579A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition |
05/28/1998 | WO1998022578A1 Methods for detecting and isolating genes |
05/28/1998 | WO1998022577A1 Fusion proteins having increased half-lives |
05/28/1998 | WO1998022575A2 Nucleotide sequence of escherichia coli pathogenicity islands |
05/28/1998 | WO1998022574A2 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |
05/28/1998 | WO1998022507A2 Receptor tyrosine kinase genes |
05/28/1998 | WO1998022506A1 Human kdel receptor |
05/28/1998 | WO1998022504A1 Novel semaphorin genes (i) |
05/28/1998 | WO1998022501A2 Secreted proteins and polynucleotides encoding them |
05/28/1998 | WO1998022496A2 Antiviral peptide derivatives |
05/28/1998 | WO1998022492A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon |
05/28/1998 | WO1998022491A1 Method for identifying genes encoding novel secreted or membrane-associated proteins |
05/28/1998 | WO1998022489A1 Novel nucleotide analogues |
05/28/1998 | WO1998022438A1 Cyclic imines as pesticides |
05/28/1998 | WO1998022145A1 Immunization of infants |
05/28/1998 | WO1998022144A2 Complexes of adenovirus with cationic molecules |
05/28/1998 | WO1998022143A1 Chimeric retrovirus/adenovirus system |
05/28/1998 | WO1998022142A1 Antisense oligonucleotide compositions for selectively killing cancer cells |
05/28/1998 | WO1998022140A2 Hybrid compositions for intracellular targeting |
05/28/1998 | WO1998022134A1 BIOSYNTHETIC GENE murG FROM $i(STREPTOCOCCUS PNEUMONIAE) |
05/28/1998 | WO1998022133A1 NOVEL FabD |
05/28/1998 | WO1998022104A2 Treatment of neurodegenerative conditions with nimesulide |
05/28/1998 | WO1998021972A2 Compounds with improved inductive effect on cartilage and bones |
05/28/1998 | WO1998021938A1 Glutathione-s-conjugate transport in plants |
05/28/1998 | WO1998016551A3 Variants of vascular endothelial cell growth factor having antagonistic properties |
05/28/1998 | WO1998014611A3 Detection and identification of non-polio enteroviruses |
05/28/1998 | WO1998012328A3 Human bad polypeptides, encoding nucleic acids and methods of use |
05/28/1998 | WO1998007862A3 Chemokine beta-16 |
05/28/1998 | WO1998002191A3 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
05/28/1998 | WO1998001550A3 Vaccine against gastro-intestinal nematodes |
05/28/1998 | DE19648715A1 DNA encoding human interleukin-16 |
05/28/1998 | DE19648011A1 Cyclische Imine Cyclic imines |
05/28/1998 | CA2275438A1 Improved methods for transducing cells |
05/28/1998 | CA2272824A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition |
05/28/1998 | CA2272823A1 Method for identifying genes encoding novel secreted or membrane-associated proteins |
05/28/1998 | CA2272747A1 Hybrid compositions for intracellular targeting |
05/28/1998 | CA2272744A1 Chimeric adenoviral vectors |
05/28/1998 | CA2272578A1 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
05/28/1998 | CA2272564A1 Transgenic plant or plants with a naturally high water content overproducing at least two amino acids of the aspartate family |
05/28/1998 | CA2272545A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon |
05/28/1998 | CA2272534A1 Carrot antifreeze polypeptides |